For health, 
with humanity

We are a world-leading company 100% focussed on everyday health. Our leading brands are built on science, innovation and human understanding and are trusted by millions of consumers globally. Our purpose is to deliver better everyday health with humanity.

Download the Haleon factsheet to learn more.

Investment case

  • Global leader 100% focused on consumer healthcare with clear purpose to deliver better everyday health with humanity
  • Exceptional portfolio of category leading brands with attractive footprint and competitive capabilities 
  • Strategy to outperform and run a responsible business, integral to all we do 
  • 4-6% organic annual sales growth1, sustainable moderate margin expansion2 and high cash conversion3
  • Attractive growth profile with capacity to invest and deliver shareholder returns

Behind the Brands with Investor Relations

While Haleon may be a relatively new name, many of our brands have been loved and trusted for generations. Join the Investor Relations team as we deep dive into some of these brands; showcasing their history and innovation

Tums: Looking closer at the brand’s history, innovation, and marketing, which combined with efficacy addresses a real health need of heartburn, making it America’s number one antacid. 


For the most up to date information on financial performance, shareholder services and more information.

Regulatory news

Annual Report 2022

Haleon has a strong portfolio of brands and is well positioned to play a vital role for people all around the world, in a sector that is growing and more relevant than ever.

You may also be interested in

Our Impact

We aim to make better everyday health more achievable, inclusive and sustainable.


Shareholder information

Learn more about managing your shares, our AGM and find FAQs.


Debt investors

Learn more about how we manage funding requirements and financial risks in support of our strategic objectives.

Contact information

If you are an institutional shareholder or equity analyst and would like information on Haleon, please contact our investor relations team.

1In the medium term (see 2022 Annual Report for definitions)

2At constant currency per annum (see 2022 Annual Report for definitions)

3Free cash flow conversion (see 2022 Annual Report for definitions)